MODIFICATION
A -- CEIRS Influenza Data Processing and Coordinating Center (DPCC)
- Notice Date
- 4/8/2013
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700 B Rockledge Room 3214 MSC7612, Bethesda, Maryland, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- RFP-NIAD-DMID-AI2013176
- Archive Date
- 4/22/2013
- Point of Contact
- Michael Welsh, Phone: 301- 451-2569, Aileene Mitchell Ford, Phone: 301-496-7288
- E-Mail Address
-
welshmi@mail.nih.gov, aileene.mitchellford@nih.gov
(welshmi@mail.nih.gov, aileene.mitchellford@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This amendment serves to change the link of the Influenza Research Database hyperlink from www.ird.org to www.fludb.org In addition the CEIRS DPCC is a new requirement and no incumbent exists. Introduction This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) small businesses, HUBZone small businesses, service-disabled veteran-owned small businesses, 8(a) small businesses, veteran-owned small businesses, woman-owned small businesses, or small disadvantaged businesses classifications; and (3) size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Information submitted in response to this notice will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code 541712 should not submit a response to this notice. A determination by the Government not to compete this requirement as a set-aside based upon responses to this notice is solely within the discretion of the Government. Responses submitted must indicate if you have a GSA schedule contract, a contract on GSA 8(a) STARS, or a contract on GSA VETS GWAC. Background Research supported and conducted by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (HHS) strives to understand, treat and ultimately prevent the myriad infectious, immunologic, and allergic diseases that threaten millions of human lives. The NIAID Division of Microbiology and Infectious Diseases (DMID) supports extramural research to control and prevent diseases caused by infectious agents. This includes basic and applied research to develop and evaluate therapeutics, vaccines, and diagnostics, which are funded through a variety of research grants and contracts. Research activities to provide more effective approaches to controlling influenza virus infections are an important component of these efforts, and span both basic and applied research on influenza virus biology and replication, pathogenesis, immunology, epidemiology, and clinical research to develop new and improved diagnostics, antiviral drugs, and vaccines. Underpinning these efforts are the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS). CEIRS is an integrated network of centers designed to bring together multidisciplinary teams of researchers that perform surveillance related research integrated with research on host immune response, viral pathogenesis, and the factors that control the emergence and transmission of influenza viruses. The overall goal of the CEIRS network is to provide the information and public health tools needed to control the impact of epidemic influenza and the threat of pandemic influenza. The CEIRS network has made significant contributions to influenza research through global surveillance studies that have provided insights into the natural history of influenza A viruses in wild birds, virus ecology and viral hosts; served to evaluate the effectiveness of strategies for controlling the spread of animal influenza viruses; provided improvement of sample collections and detection of influenza viruses in primary clinical specimens; and provided a better understanding of the antigenic diversity of influenza viruses and how influenza viruses emerge. Significant progress has also been made in the research areas of influenza pathogenesis and host response. CEIRS investigators have advanced understanding of the molecular, ecological, and environmental factors that influence pathogenesis, transmission, and evolution of influenza viruses. In addition, a significant amount of research has been conducted to characterize the protective immune response. These projects have provided information regarding correlates of immunity, as well as cross protection among different influenza virus subtypes. Among the most important was the CEIRS response to the 2009 H1N1 pandemic, in which the CEIRS network was instrumental in conducting early virus characterization studies and pre-clinical evaluation of vaccine material. Other highlights include assistance in the development of the Influenza Research Database ( www.fludb.org ), a NIAID-funded program that provides datasets and bioinformatics tools to the global research community, as well as contributions to influenza reagents and data sharing. Equally important to the influenza research community are the training and lab capacity building activities the centers support. These activities build infrastructure not only for influenza research and response, but can also be applied to other infectious diseases as well. Purpose and Objectives A contract to be awarded under a Request for Proposal (RFP) for the requirements stated herein will establish a Data Processing & Coordinating Center (DPCC) for NIAID's CEIRS network, which will collect, process, track and coordinate the diverse influenza data sets generated by the CEIRS network and facilitate the CEIRS network data management and transfer to appropriate public databases and provide website for sharing CEIRS related information and documents. All projects carried out under resultant contracts must be conducted in a manner consistent with all applicable Federal regulations and the DMID, NIAID, NIH and DHHS policies and guidelines for the conduct and oversight of research involving human subjects. The anticipated start date is on/or about March 15, 2014 with a one-year base period and six (6) one-year option periods. Capability Statement/Information Sought Sources must have the expertise, personnel, and facilities to meet the requirements of the project stated herein. Tailored capability statements submitted as a result of this notice must demonstrate the organization's qualifications and experience, specifically providing evidence as to the organization's capability to perform the requirements stated herein, with particular attention to the following: 1. Establish and manage of a state-of-the-art influenza Data Processing & Coordinating Center (DPCC) that will provide appropriate tracking, processing and coordination of data collected, generated and processed by the NIAID CEIRS network, including but not limited to the following: • Maintaining a state-of-the-art computer-based system for the collection, storage, management, security and quality control of all study data stemming from the NIAID CEIRS network. • Developing and maintaining a website that allows CEIRS investigators to efficiently upload into the DPCC, as well as performing basic queries for tracking and reporting, and a public component to provide updates on the CEIRS network. • Providing study communication, collaboration and reporting activities and maintaining close collaboration with the CEIRS network, the NIAID Bioinformatics Resource Centers (BRCs) and NIAID staff to coordinate activities and share information with DMID and DMID contractors. • Conducting CEIRS network site training, assessment and technical assistance, including the development of training materials; the conduct of training for CEIRS site staff; and the support data management and bioinformatic needs of CEIRS sites as needed. • Supporting all data tracking and reporting needs of the CEIRS network, as directed by the Contracting Officers Representative (COR). • Performing data management support to include maintenance of the results database, prompt issue resolution and documentation of data revisions. 2. The availability, adequacy and suitability of an established central facility, equipment and other resources, including computer equipment, network infrastructure, database management systems and overall information technology systems administration of the organization and all proposed subcontractors for data collection, computer processing, storage, tracking and retrieval of all study data and study-related information. 3. The ability to provide adequate scientific and technical personnel who have knowledge of influenza surveillance and basic research and expertise leading project activities both directly and indirectly through multiple partners. Must also have demonstrated ability to identify and resolve problems encountered in meeting milestones and timelines for projects of similar scope, size and complexity, including a public bioinformatics or related resource that supports infectious disease research. 4. The ability to provide a technical and administrative management infrastructure to ensure the efficient planning, implementation, oversight, and completion of all required activities. How to Submit a Response 1. Page Limitations: Interested qualified small business organizations should submit a tailored capability statement for this requirement not to exceed five (5) pages, excluding resumes, describing the organization's experience and ability to perform the efforts stated herein, which includes the following: (1) a summary list of similar work previously performed or being performed; (2) demonstrated scientific and technical ability to carry out the work; (3) the professional qualifications and specific experience of staff who may be assigned to the requirement; (4) the capability to provide the required level-of-effort on a continuing and emerging needs basis; (4) resumes for proposed key personnel, which reflect education, and previous work relevant to the proposed requirement; and (5) a general description of the facilities and other resources needed to perform the work. Tailored capability statements must also include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement (preferably placed under the eligible small business concern's name and address). Responses will be reviewed only by NIH personnel and will be held in a confidential manner. All information received within fifteen (15) days after the date of publication of this synopsis will be considered by the Government. 2. Required Business Information: • DUNS • Company Name • Company Address • Company Point of Contact, Phone and Email address • Current GSA Schedules, GSA 8(a) STARS, and/or GSA VETS GWAC appropriate to this Sources Sought • Do you have a Government approved accounting system? If so, please identify the agency that approved the system. • Type of Company (i.e., small business, 8(a), woman owned, veteran owned, etc.) as validated via the Central Contractor Registration (CCR). All organizations must register on the CCR located at http://www.ccr.gov/index.asp 3. Number of Copies: Please submit one (1) electronic copy of your capability statement in response to this SMALL BUSINESS SOURCES SOUGHT notice, to Mr. Mike Welsh, Contract Specialist, at welshmi@niaid.nih.gov in MS Word, WordPerfect or Adobe Portable Document Format (PDF). The e-mail subject line must specify RFP-NIAID-DMID-AI2013176. Facsimile and mail delivery responses will not be accepted. 4. Common Cut-off Date: Electronically submitted tailored capability statements are due no later than 2:00PM (Eastern Prevailing Time) on April 19, 2013. CAPABILITY STATEMENTS RECEIVED AFTER THIS DATE AND TIME WILL NOT BE CONSIDERED. Disclaimer and Important Notes. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response to the notice. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work stated herein. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. Responses to this notice will not be considered responses to a solicitation. Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIAD-DMID-AI2013176/listing.html)
- Place of Performance
- Address: To be determined., United States
- Record
- SN03030872-W 20130410/130408234052-962f52a73749057c1d7dc8e24646d301 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |